Centyl K Tablets
- Name:
Centyl K Tablets
- Company:
Karo Pharma AB
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 17/12/20
(Click to Download) Summary of Product Characteristics last updated on medicines.ie: 17/12/2020
Click on this link to Download PDF directly
Karo Pharma AB
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Burinex 1 mg Tablets | Active Ingredients Bumetanide |
| Medicine Name Burinex 5 mg Tablets | Active Ingredients Bumetanide |
| Medicine Name Centyl K Tablets | Active Ingredients Bendroflumethiazide, Potassium Chloride |
| Medicine Name Low Centyl K | Active Ingredients Bendroflumethiazide, Potassium Chloride |
| Medicine Name Pivmecillinam hydrochloride Karo Pharma 400 mg film-coated tablets | Active Ingredients Pivmecillinam Hydrochloride |
| Medicine Name Scheriproct Rectal Ointment | Active Ingredients Cinchocaine hydrochloride, prednisolone caproate |
| Medicine Name Scheriproct Suppositories | Active Ingredients Cinchocaine hydrochloride, prednisolone caproate |
| Medicine Name Ultraproct | Active Ingredients Cinchocaine hydrochloride, Fluocortolone caproate, Fluocortolone pivalate |
Items Per Page :
1 - 0 of 8 items.Total: Infinity pages
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 17 December 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 17 December 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 9 July 2019 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 27 March 2019 PIL
Reasons for updating
- New PIL for new product